0. DOCID:23389 SCORE: 0.00487046438781409
DOCNO: 7725562
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: diagnosis
QUALIFIER: drug therapy
QUALIFIER: drug therapy
QUALIFIER: drug therapy
QUALIFIER: diagnosis
QUALIFIER: drug therapy
QUALIFIER: drug therapy
AUTHOR: T Middelboe T
AUTHOR: L F Ovesen LF
AUTHOR: E L Mortensen EL
AUTHOR: P Bech P
AFFILIATION: Psykiatrisk afdeling E, Bispebjerg Hospital, København.
PUBTYPE: Journal Article
JOURNALTITLE: Ugeskrift for laeger.
COUNTRY: DENMARK
TITLE: [Symptoms of depression in cancer patients undergoing chemotherapy]
PUBDATE: 19950301
Symptoms of depression and anxiety were measured in a prospective follow-up study of 36 cancer patients before and during chemotherapy by means of the Hamilton rating scales and the Melancholia Scale. These scales proved useful in the examined population. Moderate or severe depression was seen in almost half of the patients before chemotherapy, but this figure decreased during follow-up. The symptomatology resembled that of primary depression, and the brief rating scales for depression seemed suitable for screening purpose. Problems in identifying morbid states of anxiety and depression are discussed.


1. DOCID:23358 SCORE: 0.00487044704688879
DOCNO: 7604470
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Adenocarcinoma, Mucinous
DESCRIPTOR: Bladder Neoplasms
DESCRIPTOR: Urinary Diversion
AUTHOR: B Djavan B
AUTHOR: S E Litwiller SE
AUTHOR: S Milchgrub S
AUTHOR: C G Roehrborn CG
AFFILIATION: Department of Surgery, University of Texas Southwestern Medical Center, Dallas 75235-9110, USA.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Urology.
COUNTRY: UNITED STATES
TITLE: Mucinous adenocarcinoma in defunctionalized bladders.
PUBDATE: 19950701
Primary adenocarcinoma of the bladder accounts for less than 2% of all bladder cancers. There is no report of such a case in a defunctionalized bladder. All reported cases of carcinoma in defunctionalized bladders were either squamous cell, signet ring cell, or transitional cell carcinoma, detected within an average of 5 years after urinary diversion, and all have been associated with chronic inflammation of the bladder. We report on 2 cases of adenocarcinoma that developed in defunctionalized bladders 30 and 8 years after ileal loop diversion for prune belly syndrome and neurogenic bladder, respectively.


2. DOCID:17514 SCORE: 0.00343082222592861
DOCNO: 8239737
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: methods
QUALIFIER: methods
QUALIFIER: methods
QUALIFIER: pathology
AUTHOR: C Rioja Sanz C
AUTHOR: M Blas Marin M
AUTHOR: J M Minguez Peman JM
AUTHOR: L A Rioja Sanz LA
AFFILIATION: Servicio de Urología, Hospital Miguel Servet, Zaragoza, España.
PUBTYPE: Journal Article
JOURNALTITLE: Archivos españoles de urología.
COUNTRY: SPAIN
TITLE: [Laparoscopic lymphadenectomy]
PUBDATE: 19930901
The limitations of the diagnostic imaging methods in determining lymph node involvement in pelvic tumors (prostatic cancer) and the high incidence of false negatives in the intraoperative frozen biopsies done during open lymphadenectomy have prompted us to develop laparoscopic staging lymphadenectomy since November, 1990. The different imaging and invasive diagnostic methods are briefly analyzed in the present article. The laparoscopic lymphadenectomy procedure is described in detail and a summary of our series is presented.


3. DOCID:16555 SCORE: 0.00337563241751901
DOCNO: 1865402
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Pregnancy Complications
QUALIFIER: complications
QUALIFIER: diagnosis
QUALIFIER: diagnosis
QUALIFIER: complications
AUTHOR: J L Davis JL
AUTHOR: M D Chen MD
AFFILIATION: Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California 90048.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: The Journal of reproductive medicine.
COUNTRY: UNITED STATES
TITLE: Gastric carcinoma presenting as an exacerbation of ulcers during pregnancy. A case report.
PUBDATE: 19910601
Gastric cancer is unusual during pregnancy. Also, because of the physiologic changes that occur with pregnancy, it is rare to see a worsening of peptic ulcers during pregnancy. A patient with an exacerbation of peptic ulcers presented with gastric carcinoma during pregnancy.


4. DOCID:23610 SCORE: 0.00332748934557577
DOCNO: 9204020
AUTHOR: J J Earnshaw JJ
AUTHOR: Y Stephenson Y
AFFILIATION: Gloucastershire Royal Hospital, England.
PUBTYPE: Journal Article
JOURNALTITLE: Journal of the Royal Society of Medicine.
COUNTRY: ENGLAND
TITLE: First two years of a follow-up breast clinic led by a nurse practitioner.
PUBDATE: 19970501
After special training a nurse practitioner ran an independent clinic for follow-up patients with breast disease. All patients referred to a single surgical firm with breast cancer and most patients with benign disease who required follow-up were included. In the first 2 years of the service 382 clinic visits were recorded (median 5/clinic, range 1-12). The nurse practitioner reviewed 236 (62%) patients alone but involved the consultant surgeon in the remainder. No significant lesion was missed in these patients. The nurse-led clinic is popular with patients and, subject to careful supervision, offers an attractive option for follow-up of patients with breast disease.


5. DOCID:16590 SCORE: 0.00322974748895767
DOCNO: 1558644
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Quality Assurance, Health Care
QUALIFIER: standards
QUALIFIER: standards
AUTHOR: J C Breckenridge JC
AUTHOR: J W Scrimger JW
AUTHOR: G C Field GC
AUTHOR: D M Robinson DM
AFFILIATION: Department of Medical Physics, Cross Cancer Institute, Edmonton, Alberta, Canada.
PUBTYPE: Journal Article
JOURNALTITLE: Medical dosimetry : official journal of the American Association of Medical Dosimetrists.
COUNTRY: UNITED STATES
TITLE: A program for quality assurance of computerized treatment planning systems.
PUBDATE: 19920301
Quality Assurance (QA) on computerized treatment planning systems is currently an area that requires considerable attention. To meet this objective a simple yet effective quality assurance program has been developed and implemented at the Cross Cancer Institute.


6. DOCID:19502 SCORE: 0.00321934188218153
DOCNO: 1932224
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: methods
QUALIFIER: therapy
AUTHOR: J P Sculier JP
AFFILIATION: Centre des Tumeurs de l'Université Libre de Bruxelles, Belgium.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Current opinion in oncology.
COUNTRY: UNITED STATES
TITLE: Intensive care in the treatment of cancer patients.
PUBDATE: 19910801
Intensive care has been important in the treatment of cancer patients during the last decade. The main indications for admission to the intensive care unit are postoperative recovery, critical complications of cancer and its treatment, intensive anticancer treatment administration monitoring, and acute disease unrelated to the neoplastic disease or its treatment. Management of such cases must take into account the patient's fragility resulting from the presence of a severe chronic underlying disease with systemic effects. In the future, intensive care may play an important role in the development of oncology not only as supportive care for patients but also in the active development of new anticancer therapies.


7. DOCID:17328 SCORE: 0.00287692439756251
DOCNO: 8444958
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Shoulder Joint
QUALIFIER: etiology
QUALIFIER: therapy
QUALIFIER: adverse effects
QUALIFIER: adverse effects
AUTHOR: K Chaudhuri K
AUTHOR: D Lonergan D
AUTHOR: I Portek I
AUTHOR: L McGuigan L
AFFILIATION: Department of Rheumatology, St. George Hospital, Kogarah, New South Wales, Australia.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: The Journal of bone and joint surgery. British volume.
COUNTRY: ENGLAND
TITLE: Septic arthritis of the shoulder after mastectomy and radiotherapy for breast carcinoma.
PUBDATE: 19930301
We report five patients who developed septic arthritis of the shoulder after cancer of the ipsilateral breast had been treated by surgery and radiotherapy. Lymphoedema was present in all cases. The infections were not obvious, having subacute onsets, and delays in diagnosis led to destruction of the joint in all but one patient.


8. DOCID:20909 SCORE: 0.00283487220999555
DOCNO: 8593724
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: etiology
AUTHOR: K Mizuno K
AUTHOR: H Okamoto H
AUTHOR: S Imamura S
AFFILIATION: Department of Dermatology, Faculty of Medicine, Kyoto University, Japan.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Clinical and experimental dermatology.
COUNTRY: ENGLAND
TITLE: Postirradiation multiple minute digitate hyperkeratoses.
PUBDATE: 19950901
We report a new case of multiple minute digitate hyperkeratoses after postmastectomy irradiation therapy for mammary cancer. This is the first case of multiple minute digitate hyperkeratoses in an Asian country as well as the third report of the disorder after irradiation. The characteristic eruption, the consistent trigger of irradiation and its occurrence in patients of different racial groups indicate that multiple minute digitate hyperkeratoses are a distinct clinical entity.


9. DOCID:18791 SCORE: 0.00280131190571625
DOCNO: 1514828
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: prevention & control
AUTHOR: S Puribhat S
AFFILIATION: National Cancer Institute, Phayathai Bangkok, Thailand.
PUBTYPE: Journal Article
JOURNALTITLE: Gan to kagaku ryoho. Cancer & chemotherapy.
COUNTRY: JAPAN
TITLE: Present status of cancer treatment in several Asian countries.
PUBDATE: 19920701
Most of Asian Countries are still developing. Hence there are constraints in cancer treatment. There are those countries with fully equipped and fully distributed like western world such as Japan, Korea and Singapore. Other with some comprehensive cancer centers but confine to only big cities with poor coverage of the population resulting in a lot of late cases of cancer patients seen. Such countries are Bangladesh, China, India, Indonesia, Malaysia, Sri-Lanka, Thailand and etc. Still a lot of countries have no facilities to cope with cancer patients such as Brunei, Kampuchea, Laos, Nepal, Vietnam and etc. International collaboration and supports are needed.


10. DOCID:19346 SCORE: 0.00267155526685039
DOCNO: 2143407
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Quality of Life
QUALIFIER: therapy
AUTHOR: J J Strain JJ
AFFILIATION: Mount Sinai Medical Center, New York, NY.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Oncology (Williston Park, N.Y.)
COUNTRY: UNITED STATES
TITLE: The evolution of quality of life evaluations in cancer therapy.
PUBDATE: 19900501
Patients' feelings, psychological and functional status, and quality of life have often been regarded as unmeasurable subjective entities that cannot be scientifically studied. But now, with better measurement tools, the cancer patient's Quality of Life can be understood in more operational terms than the "soft" subjective statements that have too often characterized the field to date. This paper addresses the issue of Quality of Life from several perspectives: 1. Historical antecedents of the concept; 2. precipitating factors; 3. evolution of the concept; 4. historical development of the measures; and 5. applications of Quality of Life assessments, including implications for research, teaching, and clinical care.


11. DOCID:18068 SCORE: 0.00257090037585412
DOCNO: 1346085
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Proto-Oncogenes
QUALIFIER: genetics
AUTHOR: A Karato A
AUTHOR: N Saijo N
AFFILIATION: Dept. of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Gan to kagaku ryoho. Cancer & chemotherapy.
COUNTRY: JAPAN
TITLE: [An overview of new prognostic factors in lung cancer]
PUBDATE: 19920101
The knowledge of prognostic factors such as TNM, performance status, and sex is essential for predicting patient outcome and optimal trial design and analysis. Recent advances in cytogenetics and molecular biology have yielded new prognostic factors such as DNA ploidy, oncogenes and oncogene product. New prognostic factors can predict patient outcome and should be incorporated for the multivariate analysis of prognostic factors. They can provide a guideline for selecting special patient population suitable for adjuvant chemotherapy even in the early stage of lung cancer.


12. DOCID:18072 SCORE: 0.00254010652727656
DOCNO: 1791893
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Autoimmunity
QUALIFIER: immunology
QUALIFIER: immunology
AUTHOR: E J Ruitenberg EJ
AFFILIATION: Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: The Netherlands journal of medicine.
COUNTRY: NETHERLANDS
TITLE: Contributions of basic immunology to human health.
PUBDATE: 19911001
Considerable progress has been achieved in immunology and the development of novel immunological intervention strategies. In this review some new concepts in immunology, and particularly the role played by T cells, are discussed: new ideas on the pathogenesis and possible treatment of autoimmune diseases, on the pathogenesis and immunological treatment of HIV infections, new approaches to transplantation, novel concepts in tumour immunology and cancer immunotherapy and the development of new (molecular) vaccines against infectious diseases. It is anticipated that these new concepts will lead to novel immunological drugs.


13. DOCID:22320 SCORE: 0.00230481846186244
DOCNO: 7728738
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: drug therapy
QUALIFIER: enzymology
AUTHOR: S Subramaniam S
AUTHOR: S Subramaniam S
AUTHOR: C S Shyamala Devi CS
AFFILIATION: Department of Biochemistry, University of Madras, India.
PUBTYPE: Journal Article
JOURNALTITLE: Cancer biochemistry biophysics.
COUNTRY: ENGLAND
TITLE: Erythrocyte antioxidant enzyme activity in CMF treated breast cancer patients.
PUBDATE: 19941001
Most of breast cancer patients are treated with CMF, which is a combination of three anticancer agents, cyclophosphamide, methotrexate and 5-fluorouracil. Metabolites of CMF induce lipid peroxidation by inactivating the antioxidant enzymes, thereby rendering the system inefficient in management of the free radical attack. Acrolein and phosphoramide mustard are the metabolites of cyclophosphamide which are among the causative agents which reduce the activity of superoxide dismultase, catalase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase and glucose-6-phosphate dehydrogenase in erythrocytes of CMF treated breast cancer patients.


14. DOCID:20132 SCORE: 0.00216420737836143
DOCNO: 9311336
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: surgery
QUALIFIER: prevention & control
QUALIFIER: therapy
QUALIFIER: adverse effects
AUTHOR: J Price J
AUTHOR: J R Purtell JR
AFFILIATION: Waukesha County Technical College, Pewaukee, WI, USA.
PUBTYPE: Journal Article
JOURNALTITLE: The American journal of nursing.
COUNTRY: UNITED STATES
TITLE: Prevention and treatment of lymphedema after breast cancer.
PUBDATE: 19970901
Through personal experience, these two health care professionals discovered that the threat of lymphedema and its risk factors is often underestimated by clinicians. What they learned may help you provide better care for your patients with breast cancer.